This report provides an integrated analysis of relationships between antimicrobial consumption in humans and food- producing animals and the occurrence of antimicrobial resistance in bacteria from humans and food- producing animals, respectively.
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 11-17 February 2024, and includes updates on SARS-CoV-2 variant classification, diphtheria, chikungunya, dengue, influenza A(H5N1), a human case of co-infection with seasonal influenza A(H3N2) and avian influenza A(H10N5), Middle East respiratory syndrome coronavirus (MERS-CoV), and an overview of respiratory virus epidemiology in the EU/EEA.
In 2024, and as of 31 of January, approximately 10 000 CHIKVD cases and no deaths have been reported worldwide. A total of eight countries reported CHIKVD cases from the America (6) and Asia (2).
Since the beginning of 2023, and as of 16 February 2024, six MERS-CoV cases, including two fatalities, have been reported with the date of onset in 2023 by Saudi Arabia (5) and the United Arab Emirates (1).
Since the beginning of 2023, and as of 16 February 2024, six MERS-CoV cases, including two fatalities, have been reported with the date of onset in 2023 by Saudi Arabia (5) and the United Arab Emirates (1).
Since the beginning of 2023, and as of 16 February 2024, six MERS-CoV cases, including two fatalities, have been reported with the date of onset in 2023 by Saudi Arabia (5) and the United Arab Emirates (1).
Since April 2012, and as of 5 February 2024, a total of 2 617 cases of MERS-CoV, including 947 deaths, have been reported by health authorities worldwide.